Difference between revisions of "TACE"
Jump to navigation
Jump to search
m |
m |
||
Line 1: | Line 1: | ||
− | Transarterial chemoembolization (TACE) refers to a number of local delivery approaches which are almost exclusively used in the treatment of [[hepatocellular carcinoma]] or hepatic metastases. Typically there is an inert lipid-based carrier such as lipiodol and an expander such as gelatin foam, along with chemotherapy. | + | Transarterial chemoembolization (TACE) refers to a number of local delivery approaches which are almost exclusively used in the treatment of [[hepatocellular carcinoma]] or hepatic metastases. Typically there is an inert lipid-based carrier such as lipiodol and an expander such as gelatin foam, along with chemotherapy. Another formulation consists of drug-eluting beads. |
Examples chemotherapies include (this list will be filled in over time): | Examples chemotherapies include (this list will be filled in over time): |
Revision as of 14:46, 19 June 2018
Transarterial chemoembolization (TACE) refers to a number of local delivery approaches which are almost exclusively used in the treatment of hepatocellular carcinoma or hepatic metastases. Typically there is an inert lipid-based carrier such as lipiodol and an expander such as gelatin foam, along with chemotherapy. Another formulation consists of drug-eluting beads.
Examples chemotherapies include (this list will be filled in over time):
- Cisplatin, Doxorubicin, Epirubicin, and Mitomycin
- Doxorubicin